Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression

M. Clendenning, Fa Macrae, Md Walsh, R. J. Walters, Stephen N Thibodeau, S. R. Gunawardena, J. D. Potter, R. W. Haile, S. Gallinger, J. L. Hopper, M. A. Jenkins, C. Rosty, J. P. Young, D. D. Buchanan

Research output: Contribution to journalArticle

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)591-593
Number of pages3
JournalClinical Genetics
Volume83
Issue number6
DOIs
StatePublished - Jun 2013

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Clendenning, M., Macrae, F., Walsh, M., Walters, R. J., Thibodeau, S. N., Gunawardena, S. R., Potter, J. D., Haile, R. W., Gallinger, S., Hopper, J. L., Jenkins, M. A., Rosty, C., Young, J. P., & Buchanan, D. D. (2013). Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression. Clinical Genetics, 83(6), 591-593. https://doi.org/10.1111/cge.12011